BCS生物药剂学分类?Active Pharmaceutical Ingredient (API) Based on scientific principles the WHO Prequalification of Medicines Programme (PQP) has identified moxifloxacin (up to 400mg oral dose) as a BCS class 1 API, eligible for BCS-based biowaiver applications. The API is thus BCS highly soluble.查看更多